Compare AdaptHealth Corp (AHCO) vs VF Corp (VFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AdaptHealth Corp vs VF Corp — how do they compare? AdaptHealth Corp trades at $5.79 (market cap $753.09M), while VF Corp trades at $14.68 (market cap $5.81B). The key difference: VF Corp is far larger — about 7.7× AdaptHealth Corp's market cap, and VF Corp pays a 2.44% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | VFC | |
|---|---|---|
Market Cap | $753.09M | $5.81B |
Sector | Health | Consumer Cyclical |
52-Week High | $13.38 | $21.55 |
52-Week Low | $5.22 | $12.21 |
Enterprise Value | $2.77B | $10.09B |
Dividend Yield | — | 2.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $5.63, up 7.85% today but remains under significant pressure after recent earnings disappointments. The stock shows bearish technical signals with oversold RSI readings, while fundamentals reveal negative profitability with a -6.82% net margin and three consecutive quarterly earnings misses. The company is restructuring by selling its diabetes unit to focus on sleep and respiratory care, but faces multiple securities fraud investigations following guidance revisions.
Despite 75% analyst buy ratings and an $11 consensus price target suggesting 95% upside, substantial risks exist including ongoing legal probes, execution challenges with new fixed-price contracts, and negative cash flow trends. The stock presents high-risk speculation amid operational restructuring and legal uncertainties.
VFC trades at $14.70, down 1.34% over 24 hours, with a bearish technical signal and neutral oscillators. Recent earnings showed a Q2 2026 miss with a loss of $0.27 per share versus a $0.22 loss expected, though Q4 2025 beat expectations. Revenue declined to $9.50 billion in 2025, with a net loss of $189.72 million, while the company maintains a gross margin of 54.97%. Deleveraging progress continues, but Vans brand performance remains a headwind.
The outlook is mixed; analyst consensus is a 'Hold' with a $17.44 price target, implying potential upside. Risks include persistent Vans weakness, macroeconomic pressures, and competitive dynamics. Positive catalysts include raised fiscal 2027 revenue guidance and margin improvements, but execution on brand turnaround is critical for stock appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About VF Corp
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →
